Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
04/2000
04/11/2000CA2009579C Insulin analogs
04/11/2000CA1340957C Nikkomycin derivatives, antimycotic compositions of nikkomycin derivatives and azole antimycotics
04/06/2000WO2000018961A2 Expression analysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
04/06/2000WO2000018959A1 Trex, a novel gene of traf-interacting ext gene family and diagnostic and therapeutic uses thereof
04/06/2000WO2000018954A2 Use of pex in the treatment of metabolic bone diseases
04/06/2000WO2000018952A1 Use of s-ydcb and b-ydcb, essential bacterial genes
04/06/2000WO2000018932A2 Receptor based antagonists and methods of making and using
04/06/2000WO2000018928A1 Treatment of wilt diseases
04/06/2000WO2000018922A2 Human carbohydrate-associated proteins
04/06/2000WO2000018921A2 Synthetic peptides having fgf receptor affinity
04/06/2000WO2000018919A1 Human kinesin-like motor protein
04/06/2000WO2000018918A2 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity
04/06/2000WO2000018917A2 α-SYNUCLEIN SUPER-MUTANTS ACCELERATE α-SYNUCLEIN AGGREGATION
04/06/2000WO2000018915A2 Membrane-associated organizational proteins
04/06/2000WO2000018914A2 Novel dkr polypeptides
04/06/2000WO2000018912A2 Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases
04/06/2000WO2000018910A1 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof
04/06/2000WO2000018907A2 Antisense-sequences for inhibiting the expression of the adhesion molecule icam-1
04/06/2000WO2000018904A2 Secreted proteins and nucleic acids encoding them
04/06/2000WO2000018903A2 Inducible genetic suppression of cellular excitability
04/06/2000WO2000018900A1 Dnas encoding novel polypeptides
04/06/2000WO2000018899A2 Angiotensin converting enzyme homolog and its use
04/06/2000WO2000018896A1 Cloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon
04/06/2000WO2000018895A1 Short peptides which selectively modulate the activity of protein kinases
04/06/2000WO2000018885A1 Methods of controlling proliferation and differentiation of stem and progenitor cells
04/06/2000WO2000018821A1 Biodegradable low molecular weight triblock polyester polyethylene glycol copolymers having reverse thermal gelation properties
04/06/2000WO2000018804A1 Tie2 agonist antibodies
04/06/2000WO2000018802A1 Polymeric hemoglobin mutants
04/06/2000WO2000018801A2 Ncam binding compounds
04/06/2000WO2000018799A1 Artemin, a novel neurotrophic factor
04/06/2000WO2000018798A1 Antifungal and antibacterial peptide
04/06/2000WO2000018797A1 Map
04/06/2000WO2000018796A2 Secretory protein- zsig48
04/06/2000WO2000018795A2 Compositions and methods for wt1 specific immunotherapy
04/06/2000WO2000018794A1 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
04/06/2000WO2000018793A1 Peptide derivative
04/06/2000WO2000018791A1 Ligand presenting assembly (lpa), method of preparation and uses thereof
04/06/2000WO2000018790A1 Synthesis of cyclic peptides
04/06/2000WO2000018784A1 ANTISENSE MODULATION OF RhoG EXPRESSION
04/06/2000WO2000018783A1 Mammaglobin, a secreted mammary-specific breast cancer protein
04/06/2000WO2000018782A2 Hrpca 9 and hrpca 10 nucleic acids and polypeptides
04/06/2000WO2000018762A1 Thrombin inhibitors
04/06/2000WO2000018437A1 Tie2 antagonist antibodies
04/06/2000WO2000018436A1 Use of compounds that reduce alpha2-antiplasmin in vivo for the preparation of a composition for the treatment of ischemic stroke
04/06/2000WO2000018431A1 Chemokine receptor peptide vaccines for treatment and prevention of diabetes
04/06/2000WO2000018428A2 Hedgehog and patched antagonists for inhibiting cell and tissue growth and differentiation and uses therefor
04/06/2000WO2000018427A1 Methods of treating diseased cells
04/06/2000WO2000018426A1 Apoptosis inducers
04/06/2000WO2000018425A1 Use of substances with oxytocin activity in order to create well-being
04/06/2000WO2000018424A1 Use of substances with oxytocin activity in order to create cell regeneration
04/06/2000WO2000018423A1 Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of lh-rh analogues
04/06/2000WO2000018422A1 Lacrimal secretion promoters or eye drops for treating keratoconjunctival failure containing as the active ingredient natriuretic peptides
04/06/2000WO2000018421A1 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions
04/06/2000WO2000018419A2 Methods for administration of antibiotics
04/06/2000WO2000018418A2 Inhibition of erythrocyte sickling by n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester
04/06/2000WO2000018417A2 Treatment of hepatitis b infection with thymosin alpha 1 and lamivudine
04/06/2000WO2000018414A1 Transplantation of neural cells for the treatment of ischemic damage due to stroke
04/06/2000WO2000018413A1 Transplantation of neural cells for the treatment of chronic pain or spasticity
04/06/2000WO2000018409A1 Use of certain drugs for treating nerve root injury
04/06/2000WO2000018385A2 Use of acylcarnitines as antitumour agents
04/06/2000WO2000018371A1 Proteinic drug delivery system using membrane mimetics
04/06/2000WO2000018365A2 Fast dissolving orally consumable films
04/06/2000WO2000018351A2 Aglyco products and methods of use
04/06/2000WO2000018254A2 Method of protecting heat- or oxygen-labile compounds to preserve activity and bioavailability
04/06/2000WO2000018232A1 Method of treatment of cardiovascular injuries
04/06/2000WO2000018231A1 Methods for treating or preventing viral infections and associated diseases
04/06/2000WO2000018212A2 Platelet-derived growth factor c, dna coding therefor, and uses thereof
04/06/2000WO2000018211A2 A novel cochlear gene coch5b2 and uses therefor
04/06/2000WO2000006735A8 Interferon alpha hybrids
04/06/2000WO2000004051A9 Growth differentiation factor promoter and uses therefor
04/06/2000WO2000001400A9 Compositions comprising endotoxin neutralizing protein and derivatives and uses thereof
04/06/2000WO1999067384A3 Prostate cancer-associated genes
04/06/2000WO1999067284A3 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
04/06/2000WO1999066054A3 Erythropoietin analog-human serum albumin fusion protein
04/06/2000WO1999064596A3 Proteins regulating gene expression
04/06/2000WO1999064585A3 Novel angiotensin receptor, production and use thereof
04/06/2000WO1999064584A3 Protein for regulating apoptosis
04/06/2000WO1999063097A3 Caspase-9 deficient animals and the use thereof
04/06/2000WO1999062944A3 Protein oligomer compositions comprising endostatin protein and methods of using the same
04/06/2000WO1999062941A3 Serpentine transmembrane antigens expressed in human cancers and uses thereof
04/06/2000WO1999061626A3 Human hydrolase homologs: n-terminal asparagine amidohydrolase, glycosyl hydrolase, glucohydrolase, biotinidase, and n-acetylglucosamine 6-p deacetylase
04/06/2000WO1999061618A3 Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
04/06/2000WO1999061468A3 The induction of antibiotic peptides by lait (scd14) protein
04/06/2000WO1999061453A3 priA
04/06/2000WO1999061057A3 Molecules targeting cd40 and tumor cells
04/06/2000WO1999059608A3 Osteoporosis treatment
04/06/2000WO1999058699A3 Transgenic plant-derived human blood coagulation factors
04/06/2000WO1999057144A3 Human transcriptional regulator molecules
04/06/2000WO1999055730A3 Polyepitope carrier protein
04/06/2000WO1999055564A9 Materials and methods for gene therapy
04/06/2000WO1999054706A3 Method of treating interstitial cystitis with recombinant hb-egf
04/06/2000WO1999053042A3 Biological material with increased expression of endogenous complement regulatory molecules
04/06/2000WO1999052858A3 Lipids
04/06/2000WO1999051748A9 Fusion proteins of mycobacterium tuberculosis antigens and their uses
04/06/2000WO1999046284A3 Molecules that home to various selected organs or tissues
04/06/2000WO1999040113A3 Lipopeptides containing an interferon fragment and uses thereof in pharmaceutical compositions
04/06/2000WO1996013594A8 Tumor-specific antibody fragments, fusion proteins, and uses thereof
04/06/2000CA2794705A1 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
04/06/2000CA2714449A1 Use of certain drugs for treating nerve root injury
04/06/2000CA2345978A1 Chemokine receptor peptide vaccines for treatment and prevention of diabetes
1 ... 2405 2406 2407 2408 2409 2410 2411 2412 2413 2414 2415 2416 2417 2418 2419 2420 2421 2422 2423 2424 2425 ... 3163